Single-dose daptomycin pharmacokinetics in chronic haemodialysis patients

Background. Daptomycin has concentration-dependent antibacterial activity against Gram-positive bacteria. Its use is increasing in haemodialysis units. The manufacturer recommends a 4–6-mg/kg dose administered every 48 hrs for patients receiving haemodialysis. However, there are no published data ab...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Salama, Noha N., Segal, Jonathan H., Churchwell, Mariann D., Patel, Jignesh H., Gao, Lihong, Heung, Michael, Mueller, Bruce A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2010
Gaiak:
Dialysis
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2902860/
https://ncbi.nlm.nih.gov/pubmed/20007981
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfp655
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak